Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Models, Statistical | 47 | 2023 | 5102 | 2.590 |
Why?
|
Biometry | 32 | 2019 | 558 | 2.560 |
Why?
|
Prostatectomy | 46 | 2023 | 1890 | 2.500 |
Why?
|
Prostatic Neoplasms | 73 | 2024 | 11124 | 2.080 |
Why?
|
Surgical Procedures, Operative | 39 | 2021 | 1876 | 1.870 |
Why?
|
Cystectomy | 16 | 2020 | 686 | 1.630 |
Why?
|
Urinary Bladder Neoplasms | 23 | 2024 | 2245 | 1.490 |
Why?
|
Regression Analysis | 30 | 2019 | 6459 | 1.360 |
Why?
|
Bayes Theorem | 9 | 2022 | 2309 | 1.360 |
Why?
|
Likelihood Functions | 24 | 2023 | 1005 | 1.340 |
Why?
|
Data Interpretation, Statistical | 30 | 2022 | 2716 | 1.340 |
Why?
|
Checklist | 18 | 2021 | 833 | 1.280 |
Why?
|
Prostate-Specific Antigen | 16 | 2024 | 2494 | 1.260 |
Why?
|
Healthcare Disparities | 25 | 2023 | 3158 | 1.180 |
Why?
|
General Surgery | 23 | 2021 | 1636 | 1.140 |
Why?
|
Accidental Falls | 10 | 2023 | 1062 | 1.010 |
Why?
|
Medical Errors | 17 | 2023 | 1297 | 0.990 |
Why?
|
Hospitals | 32 | 2023 | 3952 | 0.960 |
Why?
|
Humans | 583 | 2024 | 744343 | 0.950 |
Why?
|
Quality Improvement | 28 | 2024 | 3749 | 0.910 |
Why?
|
Male | 367 | 2024 | 350118 | 0.900 |
Why?
|
Postoperative Complications | 51 | 2022 | 15295 | 0.850 |
Why?
|
Electronic Health Records | 22 | 2023 | 4468 | 0.840 |
Why?
|
Aged | 238 | 2023 | 163280 | 0.820 |
Why?
|
SEER Program | 26 | 2023 | 1508 | 0.820 |
Why?
|
Quality Indicators, Health Care | 19 | 2024 | 1831 | 0.820 |
Why?
|
United States | 159 | 2024 | 69872 | 0.820 |
Why?
|
Robotics | 16 | 2012 | 899 | 0.800 |
Why?
|
Hospital Mortality | 24 | 2023 | 5317 | 0.790 |
Why?
|
Clinical Competence | 23 | 2021 | 4687 | 0.770 |
Why?
|
Patient Discharge | 14 | 2023 | 3313 | 0.760 |
Why?
|
Operating Rooms | 15 | 2020 | 817 | 0.750 |
Why?
|
Female | 345 | 2023 | 380194 | 0.750 |
Why?
|
Logistic Models | 46 | 2023 | 13408 | 0.720 |
Why?
|
Nephrectomy | 9 | 2020 | 1050 | 0.710 |
Why?
|
Medicare | 40 | 2023 | 6566 | 0.710 |
Why?
|
Survival Analysis | 29 | 2022 | 10252 | 0.710 |
Why?
|
Patient Readmission | 18 | 2022 | 3114 | 0.710 |
Why?
|
Terminal Care | 12 | 2023 | 1694 | 0.700 |
Why?
|
Computer Simulation | 30 | 2023 | 6196 | 0.700 |
Why?
|
Middle Aged | 226 | 2023 | 213383 | 0.690 |
Why?
|
Algorithms | 20 | 2023 | 13881 | 0.680 |
Why?
|
Prostate | 9 | 2023 | 1774 | 0.680 |
Why?
|
Laparoscopy | 18 | 2023 | 2151 | 0.670 |
Why?
|
Linear Models | 26 | 2023 | 5952 | 0.660 |
Why?
|
Binomial Distribution | 2 | 2014 | 25 | 0.660 |
Why?
|
Arthroplasty, Replacement, Knee | 11 | 2023 | 1458 | 0.650 |
Why?
|
Medication Errors | 8 | 2023 | 798 | 0.650 |
Why?
|
Health Services Accessibility | 20 | 2023 | 5137 | 0.630 |
Why?
|
Decision Support Systems, Clinical | 9 | 2023 | 1164 | 0.630 |
Why?
|
Multivariate Analysis | 30 | 2019 | 12245 | 0.610 |
Why?
|
Cluster Analysis | 14 | 2022 | 2715 | 0.600 |
Why?
|
Patient Care Team | 13 | 2018 | 2531 | 0.590 |
Why?
|
Normal Distribution | 4 | 2022 | 280 | 0.580 |
Why?
|
Antibiotics, Antineoplastic | 11 | 2012 | 692 | 0.580 |
Why?
|
Hospitalization | 21 | 2023 | 10262 | 0.570 |
Why?
|
Patient-Centered Care | 10 | 2021 | 1439 | 0.560 |
Why?
|
Urology | 3 | 2017 | 399 | 0.560 |
Why?
|
Mammaplasty | 12 | 2016 | 1204 | 0.560 |
Why?
|
Retrospective Studies | 110 | 2024 | 77449 | 0.560 |
Why?
|
Neoplasms | 33 | 2023 | 21683 | 0.550 |
Why?
|
Inpatients | 14 | 2023 | 2518 | 0.550 |
Why?
|
Proportional Hazards Models | 21 | 2021 | 12354 | 0.530 |
Why?
|
Early Detection of Cancer | 13 | 2023 | 3086 | 0.520 |
Why?
|
Adult | 175 | 2024 | 214055 | 0.520 |
Why?
|
Wounds and Injuries | 11 | 2020 | 2400 | 0.520 |
Why?
|
Doxorubicin | 15 | 2013 | 2234 | 0.510 |
Why?
|
Space Flight | 3 | 2022 | 188 | 0.510 |
Why?
|
Health Care Costs | 13 | 2023 | 3209 | 0.500 |
Why?
|
Comparative Effectiveness Research | 4 | 2018 | 681 | 0.490 |
Why?
|
Venous Thromboembolism | 3 | 2024 | 1671 | 0.490 |
Why?
|
Health Care Surveys | 12 | 2019 | 2453 | 0.490 |
Why?
|
Length of Stay | 29 | 2024 | 6309 | 0.480 |
Why?
|
Kallikreins | 2 | 2017 | 258 | 0.470 |
Why?
|
Tourniquets | 3 | 2019 | 110 | 0.470 |
Why?
|
Aged, 80 and over | 80 | 2022 | 57776 | 0.470 |
Why?
|
Emergency Treatment | 6 | 2020 | 517 | 0.460 |
Why?
|
Propensity Score | 13 | 2023 | 1781 | 0.460 |
Why?
|
Quality of Health Care | 18 | 2023 | 4371 | 0.460 |
Why?
|
Risk | 11 | 2017 | 9687 | 0.450 |
Why?
|
Medically Uninsured | 8 | 2018 | 853 | 0.450 |
Why?
|
Delivery, Obstetric | 6 | 2020 | 906 | 0.450 |
Why?
|
Longitudinal Studies | 31 | 2023 | 13989 | 0.450 |
Why?
|
Risk Assessment | 44 | 2023 | 23338 | 0.440 |
Why?
|
Primary Health Care | 10 | 2024 | 4558 | 0.430 |
Why?
|
Monte Carlo Method | 8 | 2019 | 1254 | 0.430 |
Why?
|
Liver Transplantation | 2 | 2023 | 2119 | 0.430 |
Why?
|
Internship and Residency | 15 | 2021 | 5788 | 0.430 |
Why?
|
Guideline Adherence | 13 | 2020 | 2266 | 0.430 |
Why?
|
Breast Neoplasms | 32 | 2022 | 20822 | 0.420 |
Why?
|
Hospital Costs | 7 | 2017 | 985 | 0.420 |
Why?
|
Infusion Pumps | 4 | 2023 | 163 | 0.410 |
Why?
|
Treatment Outcome | 80 | 2023 | 63114 | 0.410 |
Why?
|
Arthroplasty, Replacement, Hip | 6 | 2022 | 1462 | 0.410 |
Why?
|
Hypertension | 13 | 2022 | 8480 | 0.410 |
Why?
|
Kidney Neoplasms | 8 | 2023 | 4262 | 0.410 |
Why?
|
Research Design | 13 | 2023 | 5987 | 0.410 |
Why?
|
Pain, Postoperative | 6 | 2021 | 1643 | 0.410 |
Why?
|
Learning Curve | 4 | 2020 | 208 | 0.410 |
Why?
|
Lymph Node Excision | 8 | 2019 | 1261 | 0.410 |
Why?
|
Communication | 14 | 2023 | 3749 | 0.410 |
Why?
|
Survival Rate | 30 | 2021 | 12788 | 0.400 |
Why?
|
Carcinoma, Transitional Cell | 4 | 2021 | 808 | 0.400 |
Why?
|
Educational Measurement | 6 | 2021 | 1210 | 0.400 |
Why?
|
Attitude of Health Personnel | 14 | 2017 | 3843 | 0.390 |
Why?
|
Patient Satisfaction | 10 | 2019 | 3396 | 0.390 |
Why?
|
Military Medicine | 3 | 2017 | 176 | 0.390 |
Why?
|
Maternal Health Services | 4 | 2022 | 455 | 0.390 |
Why?
|
Electronic Mail | 4 | 2023 | 213 | 0.390 |
Why?
|
Diffusion of Innovation | 5 | 2018 | 725 | 0.380 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 | 2013 | 1519 | 0.380 |
Why?
|
Kidney Transplantation | 3 | 2023 | 4251 | 0.380 |
Why?
|
Physicians | 12 | 2023 | 4567 | 0.380 |
Why?
|
World Health Organization | 12 | 2020 | 1318 | 0.370 |
Why?
|
Neoplasm Staging | 27 | 2021 | 11031 | 0.370 |
Why?
|
Medicaid | 8 | 2023 | 2736 | 0.370 |
Why?
|
Drug Prescriptions | 4 | 2021 | 1637 | 0.360 |
Why?
|
Specialties, Surgical | 4 | 2023 | 391 | 0.360 |
Why?
|
Neoadjuvant Therapy | 8 | 2019 | 2728 | 0.360 |
Why?
|
Patient Acceptance of Health Care | 9 | 2020 | 3022 | 0.350 |
Why?
|
Intensive Care Units | 7 | 2023 | 3679 | 0.350 |
Why?
|
Infusions, Intravenous | 10 | 2023 | 2274 | 0.350 |
Why?
|
Chi-Square Distribution | 15 | 2023 | 3508 | 0.340 |
Why?
|
Clinical Trials as Topic | 11 | 2018 | 7913 | 0.340 |
Why?
|
Survivors | 13 | 2023 | 2291 | 0.340 |
Why?
|
Razoxane | 4 | 2012 | 44 | 0.340 |
Why?
|
Health Knowledge, Attitudes, Practice | 9 | 2023 | 3923 | 0.340 |
Why?
|
Medical Oncology | 3 | 2019 | 2265 | 0.330 |
Why?
|
Colorectal Neoplasms | 13 | 2023 | 6773 | 0.330 |
Why?
|
Time Factors | 50 | 2022 | 40075 | 0.330 |
Why?
|
Cross-Sectional Studies | 38 | 2023 | 25043 | 0.330 |
Why?
|
Health Expenditures | 9 | 2023 | 2348 | 0.330 |
Why?
|
Urinary Bladder | 7 | 2023 | 1172 | 0.330 |
Why?
|
Fee-for-Service Plans | 4 | 2017 | 694 | 0.330 |
Why?
|
Emergencies | 6 | 2022 | 1170 | 0.330 |
Why?
|
Patient Participation | 6 | 2020 | 1457 | 0.320 |
Why?
|
Trauma Centers | 6 | 2021 | 890 | 0.320 |
Why?
|
Accidents, Occupational | 1 | 2010 | 251 | 0.320 |
Why?
|
Mastectomy | 10 | 2020 | 1793 | 0.320 |
Why?
|
Electronics | 7 | 2022 | 322 | 0.320 |
Why?
|
Video Recording | 5 | 2021 | 949 | 0.310 |
Why?
|
Muscle Neoplasms | 2 | 2019 | 139 | 0.300 |
Why?
|
Advance Care Planning | 4 | 2019 | 662 | 0.300 |
Why?
|
Mastectomy, Segmental | 5 | 2017 | 956 | 0.300 |
Why?
|
Analgesics, Opioid | 7 | 2022 | 3674 | 0.300 |
Why?
|
Risk Factors | 64 | 2023 | 72290 | 0.300 |
Why?
|
Intraoperative Complications | 6 | 2013 | 1198 | 0.300 |
Why?
|
Education, Medical, Graduate | 7 | 2021 | 2291 | 0.290 |
Why?
|
Analysis of Variance | 14 | 2016 | 6365 | 0.290 |
Why?
|
Safety Management | 7 | 2013 | 783 | 0.290 |
Why?
|
Delivery of Health Care | 6 | 2023 | 5319 | 0.290 |
Why?
|
Databases, Factual | 23 | 2020 | 7729 | 0.290 |
Why?
|
Patient Protection and Affordable Care Act | 7 | 2023 | 1209 | 0.290 |
Why?
|
Palliative Care | 6 | 2021 | 3493 | 0.280 |
Why?
|
Androgen Antagonists | 4 | 2019 | 1377 | 0.280 |
Why?
|
Prospective Studies | 50 | 2023 | 53288 | 0.280 |
Why?
|
Vascular Surgical Procedures | 7 | 2020 | 1475 | 0.280 |
Why?
|
Statistics as Topic | 6 | 2014 | 2373 | 0.280 |
Why?
|
Quality Assurance, Health Care | 8 | 2017 | 2212 | 0.270 |
Why?
|
Confidence Intervals | 10 | 2014 | 2971 | 0.270 |
Why?
|
Diabetes Complications | 5 | 2014 | 1359 | 0.270 |
Why?
|
Maternal Mortality | 6 | 2020 | 310 | 0.270 |
Why?
|
Colectomy | 7 | 2022 | 683 | 0.270 |
Why?
|
Watchful Waiting | 3 | 2023 | 492 | 0.270 |
Why?
|
Nurses | 5 | 2020 | 2461 | 0.270 |
Why?
|
Laser Therapy | 2 | 2023 | 1072 | 0.270 |
Why?
|
Cocaine-Related Disorders | 2 | 2020 | 460 | 0.260 |
Why?
|
Clinical Trials, Phase III as Topic | 3 | 2010 | 841 | 0.260 |
Why?
|
Oximetry | 3 | 2015 | 471 | 0.260 |
Why?
|
Perinatal Mortality | 3 | 2020 | 105 | 0.260 |
Why?
|
Appendectomy | 3 | 2019 | 401 | 0.260 |
Why?
|
Workload | 5 | 2016 | 850 | 0.260 |
Why?
|
Muscles | 3 | 2019 | 1614 | 0.260 |
Why?
|
Chemotherapy, Adjuvant | 9 | 2019 | 3479 | 0.260 |
Why?
|
Quality of Life | 12 | 2023 | 12804 | 0.250 |
Why?
|
Cohort Studies | 33 | 2023 | 40561 | 0.250 |
Why?
|
Hemorrhage | 5 | 2022 | 3461 | 0.250 |
Why?
|
Developing Countries | 6 | 2021 | 2815 | 0.250 |
Why?
|
Poisson Distribution | 4 | 2015 | 513 | 0.250 |
Why?
|
Critical Care | 7 | 2023 | 2647 | 0.250 |
Why?
|
Appendicitis | 3 | 2019 | 645 | 0.250 |
Why?
|
Cesarean Section | 6 | 2022 | 1365 | 0.240 |
Why?
|
Transurethral Resection of Prostate | 3 | 2022 | 83 | 0.240 |
Why?
|
Odds Ratio | 19 | 2017 | 9849 | 0.240 |
Why?
|
Hospitals, Pediatric | 5 | 2024 | 1775 | 0.240 |
Why?
|
Follow-Up Studies | 37 | 2021 | 39050 | 0.240 |
Why?
|
Postoperative Period | 5 | 2021 | 1842 | 0.240 |
Why?
|
Occupations | 2 | 2017 | 517 | 0.240 |
Why?
|
Socioeconomic Factors | 21 | 2020 | 7785 | 0.240 |
Why?
|
Anthracyclines | 3 | 2012 | 288 | 0.240 |
Why?
|
Surgery, Computer-Assisted | 5 | 2012 | 1018 | 0.240 |
Why?
|
South Carolina | 8 | 2017 | 99 | 0.240 |
Why?
|
Patient Simulation | 2 | 2018 | 309 | 0.240 |
Why?
|
Randomized Controlled Trials as Topic | 16 | 2022 | 9959 | 0.230 |
Why?
|
Statistics, Nonparametric | 7 | 2019 | 2886 | 0.230 |
Why?
|
Ischemia | 6 | 2013 | 1907 | 0.230 |
Why?
|
Hospice Care | 3 | 2023 | 672 | 0.230 |
Why?
|
Prostatic Hyperplasia | 2 | 2022 | 523 | 0.230 |
Why?
|
Neoplasm Invasiveness | 10 | 2019 | 3616 | 0.230 |
Why?
|
Heart Diseases | 10 | 2013 | 2788 | 0.230 |
Why?
|
Health Education | 2 | 2021 | 1056 | 0.230 |
Why?
|
Rectal Neoplasms | 4 | 2020 | 1206 | 0.230 |
Why?
|
Ethics Consultation | 1 | 2024 | 52 | 0.230 |
Why?
|
Erectile Dysfunction | 6 | 2017 | 461 | 0.230 |
Why?
|
Physician-Patient Relations | 6 | 2019 | 3229 | 0.230 |
Why?
|
Child | 65 | 2024 | 77709 | 0.230 |
Why?
|
Hospitals, Community | 3 | 2016 | 348 | 0.230 |
Why?
|
Dementia | 3 | 2023 | 2518 | 0.230 |
Why?
|
Benchmarking | 8 | 2018 | 1042 | 0.230 |
Why?
|
Cardiotoxins | 2 | 2013 | 41 | 0.220 |
Why?
|
Ventricular Septum | 1 | 2023 | 73 | 0.220 |
Why?
|
Surgery Department, Hospital | 4 | 2012 | 175 | 0.220 |
Why?
|
Extremities | 3 | 2018 | 865 | 0.220 |
Why?
|
Efficiency | 3 | 2016 | 462 | 0.220 |
Why?
|
Attitude to Computers | 4 | 2018 | 202 | 0.220 |
Why?
|
Iodine | 3 | 2022 | 286 | 0.220 |
Why?
|
Decision Support Techniques | 3 | 2018 | 1956 | 0.220 |
Why?
|
Astronauts | 2 | 2022 | 79 | 0.220 |
Why?
|
Respiratory Insufficiency | 2 | 2022 | 1199 | 0.220 |
Why?
|
Military Personnel | 6 | 2019 | 1133 | 0.220 |
Why?
|
Erythroblasts | 1 | 2023 | 150 | 0.220 |
Why?
|
Data Mining | 3 | 2013 | 537 | 0.220 |
Why?
|
Registries | 10 | 2023 | 8089 | 0.220 |
Why?
|
Boston | 20 | 2021 | 9313 | 0.220 |
Why?
|
Medical Records Systems, Computerized | 4 | 2009 | 1205 | 0.210 |
Why?
|
Reimbursement Mechanisms | 2 | 2019 | 670 | 0.210 |
Why?
|
First Aid | 2 | 2019 | 65 | 0.210 |
Why?
|
Adolescent | 59 | 2023 | 85781 | 0.210 |
Why?
|
Medical Audit | 4 | 2016 | 467 | 0.210 |
Why?
|
Esophagectomy | 2 | 2020 | 447 | 0.210 |
Why?
|
Pulmonary Atresia | 1 | 2023 | 160 | 0.210 |
Why?
|
Reproducibility of Results | 18 | 2022 | 19905 | 0.210 |
Why?
|
Urethral Obstruction | 1 | 2022 | 56 | 0.210 |
Why?
|
Pharmaceutical Preparations | 5 | 2023 | 1071 | 0.210 |
Why?
|
Surgery, Plastic | 3 | 2016 | 624 | 0.210 |
Why?
|
Population Surveillance | 3 | 2010 | 2616 | 0.210 |
Why?
|
Medication Systems, Hospital | 3 | 2018 | 158 | 0.210 |
Why?
|
Infant, Low Birth Weight | 2 | 2023 | 850 | 0.210 |
Why?
|
Cryotherapy | 2 | 2014 | 155 | 0.210 |
Why?
|
Urination | 3 | 2012 | 204 | 0.210 |
Why?
|
Least-Squares Analysis | 4 | 1998 | 379 | 0.210 |
Why?
|
Telephone | 3 | 2014 | 617 | 0.210 |
Why?
|
Probability | 12 | 2023 | 2505 | 0.200 |
Why?
|
Perception | 3 | 2018 | 1198 | 0.200 |
Why?
|
Hospital Information Systems | 2 | 2017 | 395 | 0.200 |
Why?
|
Age Factors | 20 | 2018 | 18370 | 0.200 |
Why?
|
Aerospace Medicine | 1 | 2022 | 84 | 0.200 |
Why?
|
Aftercare | 4 | 2023 | 866 | 0.200 |
Why?
|
Medical Order Entry Systems | 3 | 2013 | 545 | 0.200 |
Why?
|
Peer Group | 2 | 2020 | 635 | 0.200 |
Why?
|
Radiotherapy, Adjuvant | 8 | 2017 | 1770 | 0.200 |
Why?
|
Comorbidity | 14 | 2018 | 10388 | 0.190 |
Why?
|
Echocardiography | 15 | 2013 | 5102 | 0.190 |
Why?
|
Program Evaluation | 7 | 2018 | 2488 | 0.190 |
Why?
|
Biostatistics | 3 | 2015 | 162 | 0.190 |
Why?
|
Behavior Therapy | 3 | 2014 | 865 | 0.190 |
Why?
|
Colorectal Surgery | 1 | 2023 | 128 | 0.190 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 14 | 2019 | 11524 | 0.190 |
Why?
|
Health Records, Personal | 2 | 2012 | 124 | 0.190 |
Why?
|
Minority Groups | 6 | 2020 | 1223 | 0.190 |
Why?
|
Antihypertensive Agents | 4 | 2021 | 2046 | 0.180 |
Why?
|
Access to Information | 1 | 2023 | 320 | 0.180 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2020 | 941 | 0.180 |
Why?
|
Sex Distribution | 9 | 2016 | 2297 | 0.180 |
Why?
|
Age Distribution | 10 | 2013 | 2902 | 0.180 |
Why?
|
Preoperative Care | 5 | 2016 | 2250 | 0.180 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 441 | 0.180 |
Why?
|
Hospital Administration | 2 | 2014 | 353 | 0.180 |
Why?
|
Ureteral Neoplasms | 1 | 2021 | 111 | 0.180 |
Why?
|
Carcinoma, Ductal, Breast | 4 | 2012 | 1101 | 0.180 |
Why?
|
Nurse Midwives | 1 | 2020 | 24 | 0.180 |
Why?
|
Injury Severity Score | 7 | 2020 | 1014 | 0.180 |
Why?
|
Young Adult | 33 | 2021 | 56430 | 0.180 |
Why?
|
Preventive Health Services | 2 | 2018 | 575 | 0.180 |
Why?
|
Massachusetts | 14 | 2021 | 8663 | 0.180 |
Why?
|
Psychotherapy | 2 | 2020 | 1643 | 0.180 |
Why?
|
Diverticulitis | 1 | 2022 | 171 | 0.180 |
Why?
|
Mars | 1 | 2019 | 30 | 0.180 |
Why?
|
Convalescence | 1 | 2020 | 105 | 0.180 |
Why?
|
Tracheostomy | 1 | 2023 | 401 | 0.180 |
Why?
|
Ambulatory Surgical Procedures | 3 | 2023 | 454 | 0.180 |
Why?
|
Combined Modality Therapy | 15 | 2019 | 8642 | 0.170 |
Why?
|
Leadership | 6 | 2021 | 1357 | 0.170 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 257 | 0.170 |
Why?
|
Urinary Incontinence | 6 | 2017 | 496 | 0.170 |
Why?
|
Troponin T | 7 | 2012 | 754 | 0.170 |
Why?
|
Pulmonary Valve | 1 | 2023 | 437 | 0.170 |
Why?
|
Software | 8 | 2023 | 4443 | 0.170 |
Why?
|
Respiratory Sounds | 8 | 2006 | 696 | 0.170 |
Why?
|
Veterans | 5 | 2022 | 2519 | 0.170 |
Why?
|
Acinetobacter Infections | 1 | 2019 | 69 | 0.170 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2020 | 85 | 0.170 |
Why?
|
Diabetes Mellitus | 5 | 2022 | 5751 | 0.170 |
Why?
|
Thinness | 1 | 2023 | 480 | 0.170 |
Why?
|
Cancer Care Facilities | 4 | 2018 | 402 | 0.170 |
Why?
|
India | 7 | 2020 | 2197 | 0.170 |
Why?
|
Residence Characteristics | 4 | 2022 | 2050 | 0.170 |
Why?
|
Sample Size | 4 | 2014 | 845 | 0.170 |
Why?
|
Brachytherapy | 3 | 2018 | 1248 | 0.170 |
Why?
|
Blood Pressure | 8 | 2021 | 8554 | 0.170 |
Why?
|
CD4 Lymphocyte Count | 3 | 2010 | 2559 | 0.170 |
Why?
|
Family Practice | 1 | 2002 | 516 | 0.170 |
Why?
|
Insurance Coverage | 7 | 2023 | 1901 | 0.160 |
Why?
|
Patient Education as Topic | 4 | 2021 | 2278 | 0.160 |
Why?
|
Child, Preschool | 36 | 2023 | 41006 | 0.160 |
Why?
|
Urinary Bladder, Overactive | 1 | 2020 | 106 | 0.160 |
Why?
|
Urban Health | 2 | 2006 | 547 | 0.160 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2022 | 1186 | 0.160 |
Why?
|
Cardiovascular Diseases | 11 | 2018 | 15165 | 0.160 |
Why?
|
Adenocarcinoma | 8 | 2017 | 6364 | 0.160 |
Why?
|
Physicians, Primary Care | 2 | 2023 | 591 | 0.160 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2002 | 657 | 0.160 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2023 | 1536 | 0.160 |
Why?
|
Surgical Flaps | 4 | 2010 | 1640 | 0.160 |
Why?
|
Esophageal Neoplasms | 3 | 2020 | 1583 | 0.160 |
Why?
|
Surgical Sponges | 2 | 2008 | 46 | 0.160 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 3 | 2017 | 949 | 0.160 |
Why?
|
Body Mass Index | 13 | 2022 | 12720 | 0.160 |
Why?
|
Tetralogy of Fallot | 1 | 2023 | 623 | 0.160 |
Why?
|
Minority Health | 1 | 2019 | 87 | 0.160 |
Why?
|
Sex Factors | 14 | 2021 | 10397 | 0.160 |
Why?
|
Adiposity | 4 | 2013 | 1807 | 0.160 |
Why?
|
Health Facilities | 2 | 2020 | 573 | 0.160 |
Why?
|
Academic Medical Centers | 10 | 2023 | 2759 | 0.160 |
Why?
|
Infant, Newborn | 20 | 2023 | 25625 | 0.160 |
Why?
|
Child, Hospitalized | 2 | 2017 | 174 | 0.160 |
Why?
|
Mouth Neoplasms | 1 | 2023 | 601 | 0.160 |
Why?
|
Kidney Failure, Chronic | 5 | 2017 | 2538 | 0.160 |
Why?
|
Nutrition Surveys | 5 | 2024 | 1660 | 0.160 |
Why?
|
Liver Neoplasms | 8 | 2023 | 4253 | 0.160 |
Why?
|
Inservice Training | 3 | 2017 | 392 | 0.160 |
Why?
|
Life Expectancy | 5 | 2019 | 1184 | 0.150 |
Why?
|
Communications Media | 1 | 2018 | 43 | 0.150 |
Why?
|
Cardiomyopathies | 5 | 2012 | 1912 | 0.150 |
Why?
|
Microcomputers | 1 | 2018 | 147 | 0.150 |
Why?
|
Psychometrics | 4 | 2020 | 3002 | 0.150 |
Why?
|
Patients | 2 | 2016 | 900 | 0.150 |
Why?
|
Decision Trees | 1 | 2019 | 506 | 0.150 |
Why?
|
Appendiceal Neoplasms | 1 | 2019 | 146 | 0.150 |
Why?
|
Carcinoma, Renal Cell | 3 | 2019 | 3143 | 0.150 |
Why?
|
Health Surveys | 7 | 2018 | 4037 | 0.150 |
Why?
|
Wound Infection | 1 | 2019 | 242 | 0.150 |
Why?
|
Equipment Safety | 2 | 2016 | 264 | 0.150 |
Why?
|
Surgical Instruments | 2 | 2012 | 395 | 0.150 |
Why?
|
Professional-Family Relations | 2 | 2018 | 482 | 0.150 |
Why?
|
Fontan Procedure | 1 | 2023 | 778 | 0.150 |
Why?
|
Competency-Based Education | 2 | 2010 | 211 | 0.150 |
Why?
|
Hospitals, Teaching | 4 | 2017 | 1179 | 0.150 |
Why?
|
Periodontal Diseases | 2 | 2019 | 449 | 0.150 |
Why?
|
Travel | 1 | 2023 | 788 | 0.150 |
Why?
|
Heart | 7 | 2023 | 4467 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 10 | 2018 | 6538 | 0.150 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2023 | 780 | 0.150 |
Why?
|
Physical Exertion | 1 | 2020 | 695 | 0.150 |
Why?
|
Clinical Clerkship | 3 | 2013 | 532 | 0.150 |
Why?
|
Pandemics | 8 | 2023 | 8388 | 0.140 |
Why?
|
Feedback | 2 | 2023 | 795 | 0.140 |
Why?
|
Health Care Reform | 4 | 2019 | 1261 | 0.140 |
Why?
|
Physicians, Family | 2 | 2009 | 345 | 0.140 |
Why?
|
Malpractice | 8 | 2007 | 572 | 0.140 |
Why?
|
Incidence | 19 | 2023 | 20947 | 0.140 |
Why?
|
Health Status Disparities | 3 | 2023 | 1797 | 0.140 |
Why?
|
Hospital Units | 1 | 2017 | 141 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 3 | 2018 | 783 | 0.140 |
Why?
|
Salvage Therapy | 2 | 2014 | 1275 | 0.140 |
Why?
|
Sentinel Lymph Node Biopsy | 3 | 2010 | 709 | 0.140 |
Why?
|
Meta-Analysis as Topic | 1 | 2001 | 1344 | 0.140 |
Why?
|
Surgicenters | 1 | 2016 | 46 | 0.140 |
Why?
|
Forecasting | 3 | 2017 | 2951 | 0.140 |
Why?
|
Intestinal Obstruction | 2 | 2018 | 424 | 0.140 |
Why?
|
Midwifery | 1 | 2017 | 132 | 0.140 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2017 | 108 | 0.140 |
Why?
|
Behavioral Risk Factor Surveillance System | 4 | 2019 | 199 | 0.140 |
Why?
|
Health Communication | 1 | 2019 | 214 | 0.140 |
Why?
|
Urologic Neoplasms | 2 | 2017 | 318 | 0.140 |
Why?
|
Medical Staff, Hospital | 2 | 2011 | 603 | 0.140 |
Why?
|
Substance-Related Disorders | 3 | 2023 | 4258 | 0.140 |
Why?
|
Markov Chains | 2 | 2019 | 969 | 0.140 |
Why?
|
Lawyers | 1 | 2016 | 38 | 0.140 |
Why?
|
National Health Insurance, United States | 1 | 2016 | 104 | 0.140 |
Why?
|
Predictive Value of Tests | 15 | 2023 | 15076 | 0.130 |
Why?
|
Medication Adherence | 4 | 2021 | 2063 | 0.130 |
Why?
|
Hypoalbuminemia | 1 | 2016 | 87 | 0.130 |
Why?
|
Peripheral Vascular Diseases | 2 | 2009 | 550 | 0.130 |
Why?
|
Health Status Indicators | 3 | 2011 | 969 | 0.130 |
Why?
|
Health Resources | 3 | 2013 | 911 | 0.130 |
Why?
|
Patient Compliance | 4 | 2014 | 2684 | 0.130 |
Why?
|
Lymphatic Metastasis | 6 | 2019 | 2924 | 0.130 |
Why?
|
Wounds, Gunshot | 1 | 2021 | 563 | 0.130 |
Why?
|
Nurse-Patient Relations | 1 | 2016 | 101 | 0.130 |
Why?
|
Pilot Projects | 11 | 2020 | 8324 | 0.130 |
Why?
|
Critical Illness | 6 | 2020 | 2670 | 0.130 |
Why?
|
Surgical Wound Infection | 5 | 2016 | 1540 | 0.130 |
Why?
|
Ventricular Function, Left | 9 | 2012 | 3670 | 0.130 |
Why?
|
Recovery of Function | 7 | 2020 | 2925 | 0.130 |
Why?
|
Postoperative Care | 3 | 2021 | 1486 | 0.130 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2018 | 2020 | 0.130 |
Why?
|
Task Performance and Analysis | 3 | 2018 | 780 | 0.130 |
Why?
|
Health Behavior | 5 | 2022 | 2636 | 0.130 |
Why?
|
Personnel, Hospital | 1 | 2017 | 283 | 0.130 |
Why?
|
Coronary Disease | 3 | 2005 | 6077 | 0.130 |
Why?
|
Sampling Studies | 4 | 2015 | 623 | 0.130 |
Why?
|
Veterans Health | 1 | 2017 | 216 | 0.130 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 613 | 0.130 |
Why?
|
National Health Programs | 1 | 1998 | 445 | 0.130 |
Why?
|
Cross-Cultural Comparison | 1 | 1998 | 651 | 0.130 |
Why?
|
Epidemiologic Methods | 4 | 2012 | 1364 | 0.130 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2016 | 189 | 0.130 |
Why?
|
Mutagenicity Tests | 1 | 1994 | 46 | 0.130 |
Why?
|
Population Density | 1 | 2015 | 196 | 0.130 |
Why?
|
Clinical Protocols | 2 | 2018 | 1462 | 0.130 |
Why?
|
Controlled Clinical Trials as Topic | 2 | 2009 | 187 | 0.130 |
Why?
|
Oxytocics | 1 | 2015 | 68 | 0.130 |
Why?
|
Urothelium | 1 | 2017 | 277 | 0.130 |
Why?
|
Arrhythmias, Cardiac | 2 | 2023 | 2268 | 0.130 |
Why?
|
Salaries and Fringe Benefits | 1 | 2017 | 264 | 0.130 |
Why?
|
Postpartum Period | 2 | 2018 | 1086 | 0.130 |
Why?
|
Carcinoma in Situ | 2 | 2012 | 806 | 0.130 |
Why?
|
Emergency Service, Hospital | 6 | 2021 | 7659 | 0.130 |
Why?
|
Reminder Systems | 1 | 2018 | 371 | 0.120 |
Why?
|
Ghana | 3 | 2020 | 286 | 0.120 |
Why?
|
HIV | 1 | 2002 | 1604 | 0.120 |
Why?
|
Heart Arrest | 3 | 2021 | 1470 | 0.120 |
Why?
|
Tachycardia, Ventricular | 1 | 2023 | 1273 | 0.120 |
Why?
|
Endovascular Procedures | 2 | 2022 | 1979 | 0.120 |
Why?
|
Endpoint Determination | 1 | 2017 | 601 | 0.120 |
Why?
|
Marital Status | 1 | 2016 | 437 | 0.120 |
Why?
|
Goals | 2 | 2019 | 706 | 0.120 |
Why?
|
Office Visits | 2 | 2016 | 598 | 0.120 |
Why?
|
Traumatology | 1 | 2015 | 88 | 0.120 |
Why?
|
Health Benefit Plans, Employee | 1 | 2017 | 332 | 0.120 |
Why?
|
Health Services Needs and Demand | 3 | 2019 | 1411 | 0.120 |
Why?
|
Medical Records | 4 | 2012 | 1413 | 0.120 |
Why?
|
Nursing Services | 1 | 2013 | 8 | 0.120 |
Why?
|
Cardiovascular Agents | 4 | 2010 | 850 | 0.120 |
Why?
|
Infant Mortality | 2 | 2016 | 754 | 0.120 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2007 | 424 | 0.120 |
Why?
|
Insurance Benefits | 1 | 2016 | 183 | 0.120 |
Why?
|
Terminally Ill | 1 | 2016 | 238 | 0.120 |
Why?
|
Unnecessary Procedures | 3 | 2017 | 432 | 0.120 |
Why?
|
Pneumonia | 4 | 2020 | 2133 | 0.120 |
Why?
|
Health Status | 5 | 2018 | 4034 | 0.120 |
Why?
|
Toxicology | 1 | 1994 | 106 | 0.120 |
Why?
|
Managed Care Programs | 1 | 2019 | 950 | 0.120 |
Why?
|
Labor, Obstetric | 1 | 2017 | 333 | 0.120 |
Why?
|
Biomedical Technology | 1 | 2016 | 220 | 0.120 |
Why?
|
Guidelines as Topic | 3 | 2017 | 1405 | 0.120 |
Why?
|
Foreign Bodies | 2 | 2008 | 399 | 0.120 |
Why?
|
Digestive System Surgical Procedures | 2 | 2016 | 576 | 0.120 |
Why?
|
Disease-Free Survival | 10 | 2013 | 6895 | 0.120 |
Why?
|
Infant | 25 | 2023 | 35136 | 0.120 |
Why?
|
Smoking | 9 | 2024 | 8987 | 0.120 |
Why?
|
Vaginal Smears | 2 | 2021 | 511 | 0.120 |
Why?
|
Computers | 1 | 2016 | 612 | 0.120 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2015 | 230 | 0.120 |
Why?
|
Cost Savings | 4 | 2023 | 926 | 0.120 |
Why?
|
Child Health Services | 3 | 2013 | 667 | 0.120 |
Why?
|
Coronary Artery Bypass | 3 | 2019 | 2289 | 0.110 |
Why?
|
Education, Medical | 2 | 2017 | 1721 | 0.110 |
Why?
|
Health Promotion | 3 | 2018 | 2205 | 0.110 |
Why?
|
Computational Biology | 2 | 2005 | 3521 | 0.110 |
Why?
|
Air Pollution | 6 | 1996 | 2286 | 0.110 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2569 | 0.110 |
Why?
|
Problem-Based Learning | 1 | 2017 | 361 | 0.110 |
Why?
|
Intention | 1 | 2016 | 341 | 0.110 |
Why?
|
Ethics, Medical | 1 | 1998 | 792 | 0.110 |
Why?
|
Directive Counseling | 1 | 2014 | 166 | 0.110 |
Why?
|
Siblings | 3 | 2013 | 854 | 0.110 |
Why?
|
Certificate of Need | 1 | 2012 | 12 | 0.110 |
Why?
|
Nursing Care | 1 | 2013 | 74 | 0.110 |
Why?
|
Spinal Fusion | 2 | 2019 | 1241 | 0.110 |
Why?
|
Florida | 3 | 2018 | 435 | 0.110 |
Why?
|
Pregnancy | 15 | 2022 | 29144 | 0.110 |
Why?
|
Capacity Building | 1 | 2015 | 248 | 0.110 |
Why?
|
Muscle, Smooth | 1 | 2017 | 934 | 0.110 |
Why?
|
Blood Transfusion | 6 | 2017 | 1301 | 0.110 |
Why?
|
Memory, Short-Term | 1 | 2019 | 975 | 0.110 |
Why?
|
Leg | 2 | 2009 | 1116 | 0.110 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2024 | 1354 | 0.110 |
Why?
|
Muscle Tonus | 1 | 2012 | 81 | 0.110 |
Why?
|
Surgical Stomas | 1 | 2012 | 43 | 0.110 |
Why?
|
Referral and Consultation | 3 | 2023 | 3528 | 0.110 |
Why?
|
Mammography | 6 | 2021 | 2476 | 0.110 |
Why?
|
Vocabulary, Controlled | 1 | 2013 | 170 | 0.110 |
Why?
|
Matched-Pair Analysis | 2 | 2003 | 288 | 0.110 |
Why?
|
Triage | 1 | 2019 | 976 | 0.110 |
Why?
|
Hospitals, Military | 3 | 2017 | 67 | 0.110 |
Why?
|
Antineoplastic Agents | 11 | 2016 | 13695 | 0.110 |
Why?
|
Hospital Administrators | 1 | 2012 | 57 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2021 | 694 | 0.110 |
Why?
|
Personnel Selection | 1 | 2014 | 189 | 0.110 |
Why?
|
Internationality | 3 | 2016 | 1003 | 0.110 |
Why?
|
Manikins | 1 | 2014 | 238 | 0.110 |
Why?
|
Testicular Neoplasms | 1 | 2018 | 804 | 0.110 |
Why?
|
Ventricular Remodeling | 3 | 2023 | 1224 | 0.100 |
Why?
|
Caregivers | 2 | 2023 | 2094 | 0.100 |
Why?
|
Hormone Replacement Therapy | 1 | 2018 | 745 | 0.100 |
Why?
|
Insurance Carriers | 1 | 2014 | 157 | 0.100 |
Why?
|
Pneumonectomy | 2 | 2017 | 1094 | 0.100 |
Why?
|
Telemedicine | 2 | 2023 | 2872 | 0.100 |
Why?
|
Endarterectomy, Carotid | 1 | 2017 | 546 | 0.100 |
Why?
|
Health Services | 1 | 2017 | 758 | 0.100 |
Why?
|
Hemochromatosis | 1 | 2013 | 184 | 0.100 |
Why?
|
Smoking Cessation | 1 | 2024 | 2071 | 0.100 |
Why?
|
Lung Neoplasms | 5 | 2023 | 13102 | 0.100 |
Why?
|
Depression | 3 | 2023 | 7766 | 0.100 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2018 | 1205 | 0.100 |
Why?
|
Heart Defects, Congenital | 3 | 2023 | 4584 | 0.100 |
Why?
|
Case-Control Studies | 8 | 2023 | 21746 | 0.100 |
Why?
|
Professional Competence | 1 | 2015 | 447 | 0.100 |
Why?
|
Alzheimer Disease | 2 | 2023 | 8037 | 0.100 |
Why?
|
Postpartum Hemorrhage | 1 | 2015 | 258 | 0.100 |
Why?
|
Practice Guidelines as Topic | 6 | 2020 | 7279 | 0.100 |
Why?
|
Internet | 2 | 2016 | 3064 | 0.100 |
Why?
|
Thromboembolism | 1 | 2018 | 986 | 0.100 |
Why?
|
Thyroid Neoplasms | 3 | 2022 | 2282 | 0.100 |
Why?
|
Anticoagulants | 2 | 2024 | 4599 | 0.100 |
Why?
|
Acute Kidney Injury | 2 | 2021 | 1972 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2017 | 9239 | 0.100 |
Why?
|
Feasibility Studies | 6 | 2023 | 5078 | 0.100 |
Why?
|
Data Collection | 6 | 2011 | 3341 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1524 | 0.100 |
Why?
|
Veins | 3 | 2010 | 770 | 0.100 |
Why?
|
Interprofessional Relations | 3 | 2015 | 1011 | 0.100 |
Why?
|
Anal Canal | 1 | 2014 | 376 | 0.100 |
Why?
|
Economic Competition | 1 | 2013 | 214 | 0.100 |
Why?
|
Oxytocin | 1 | 2015 | 394 | 0.100 |
Why?
|
Health Care Coalitions | 1 | 2011 | 35 | 0.100 |
Why?
|
Patient Selection | 3 | 2020 | 4215 | 0.100 |
Why?
|
Geographic Information Systems | 2 | 2020 | 281 | 0.100 |
Why?
|
Intraoperative Care | 3 | 2012 | 767 | 0.100 |
Why?
|
Surgical Mesh | 2 | 2010 | 276 | 0.100 |
Why?
|
Fluorouracil | 8 | 2005 | 1619 | 0.100 |
Why?
|
Cause of Death | 5 | 2016 | 3584 | 0.100 |
Why?
|
Ambulatory Care | 4 | 2022 | 2708 | 0.100 |
Why?
|
Facial Transplantation | 1 | 2013 | 226 | 0.100 |
Why?
|
Pregnancy Complications | 2 | 2016 | 2861 | 0.090 |
Why?
|
Self Efficacy | 2 | 2014 | 616 | 0.090 |
Why?
|
Sutures | 2 | 2010 | 299 | 0.090 |
Why?
|
Genetic Testing | 1 | 2023 | 3444 | 0.090 |
Why?
|
Pancreatic Neoplasms | 5 | 2018 | 5256 | 0.090 |
Why?
|
Axilla | 2 | 2010 | 595 | 0.090 |
Why?
|
Pregnancy Outcome | 2 | 2019 | 2795 | 0.090 |
Why?
|
Staphylococcal Infections | 1 | 2019 | 1400 | 0.090 |
Why?
|
Polyglactin 910 | 1 | 2010 | 59 | 0.090 |
Why?
|
Health Services Research | 3 | 2019 | 1836 | 0.090 |
Why?
|
Heart Failure | 6 | 2020 | 10900 | 0.090 |
Why?
|
Androgens | 1 | 2018 | 1281 | 0.090 |
Why?
|
Resuscitation | 1 | 2015 | 658 | 0.090 |
Why?
|
Mathematical Computing | 1 | 1990 | 147 | 0.090 |
Why?
|
Culture | 1 | 2014 | 633 | 0.090 |
Why?
|
Rectus Abdominis | 1 | 2010 | 97 | 0.090 |
Why?
|
Work Schedule Tolerance | 2 | 2016 | 565 | 0.090 |
Why?
|
Physician's Role | 1 | 2017 | 943 | 0.090 |
Why?
|
Patient Access to Records | 1 | 2011 | 118 | 0.090 |
Why?
|
Patient Identification Systems | 1 | 2010 | 79 | 0.090 |
Why?
|
Colposcopy | 1 | 2010 | 144 | 0.090 |
Why?
|
Income | 6 | 2024 | 1913 | 0.090 |
Why?
|
Canada | 4 | 2019 | 2065 | 0.090 |
Why?
|
Carotid Stenosis | 1 | 2017 | 854 | 0.090 |
Why?
|
Cranial Irradiation | 1 | 2012 | 401 | 0.090 |
Why?
|
Renal Artery | 1 | 2012 | 398 | 0.090 |
Why?
|
Fluvoxamine | 2 | 1999 | 74 | 0.090 |
Why?
|
Models, Theoretical | 3 | 2016 | 3589 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2021 | 2208 | 0.090 |
Why?
|
Endocrine System Diseases | 1 | 2012 | 248 | 0.090 |
Why?
|
Breast Self-Examination | 1 | 2009 | 34 | 0.090 |
Why?
|
Headache | 2 | 2021 | 1226 | 0.090 |
Why?
|
New Jersey | 1 | 2010 | 290 | 0.090 |
Why?
|
Ethylene Glycol | 1 | 2009 | 29 | 0.090 |
Why?
|
Health Services for the Aged | 1 | 2012 | 269 | 0.090 |
Why?
|
Hospitals, Urban | 2 | 2010 | 499 | 0.090 |
Why?
|
Hospitals, General | 3 | 2023 | 749 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2022 | 3966 | 0.090 |
Why?
|
Phlebotomy | 1 | 2010 | 141 | 0.090 |
Why?
|
Patient Care | 3 | 2023 | 640 | 0.090 |
Why?
|
Narcotics | 1 | 2011 | 343 | 0.090 |
Why?
|
Evidence-Based Medicine | 5 | 2018 | 3610 | 0.090 |
Why?
|
Family | 5 | 2020 | 3147 | 0.090 |
Why?
|
Abdomen | 1 | 2015 | 1118 | 0.090 |
Why?
|
Hospital Bed Capacity | 1 | 2010 | 214 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2005 | 2073 | 0.080 |
Why?
|
Cervical Vertebrae | 1 | 2015 | 975 | 0.080 |
Why?
|
Heart Ventricles | 4 | 2023 | 3821 | 0.080 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2009 | 103 | 0.080 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2012 | 806 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2012 | 1107 | 0.080 |
Why?
|
Case Management | 1 | 2011 | 286 | 0.080 |
Why?
|
Spinal Fractures | 1 | 2015 | 696 | 0.080 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2010 | 215 | 0.080 |
Why?
|
Body Water | 1 | 2010 | 343 | 0.080 |
Why?
|
Insurance, Health | 2 | 2019 | 2494 | 0.080 |
Why?
|
Cardiotonic Agents | 1 | 2012 | 535 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1504 | 0.080 |
Why?
|
Specialization | 1 | 2013 | 777 | 0.080 |
Why?
|
Activities of Daily Living | 1 | 2018 | 2418 | 0.080 |
Why?
|
Random Allocation | 4 | 2022 | 2429 | 0.080 |
Why?
|
Neoplasm Metastasis | 5 | 2019 | 4851 | 0.080 |
Why?
|
Suture Techniques | 2 | 2010 | 798 | 0.080 |
Why?
|
Emotions | 2 | 2011 | 2661 | 0.080 |
Why?
|
Mass Screening | 7 | 2021 | 5255 | 0.080 |
Why?
|
Risk Adjustment | 3 | 2017 | 594 | 0.080 |
Why?
|
Fees, Pharmaceutical | 1 | 2008 | 64 | 0.080 |
Why?
|
Prescription Drugs | 2 | 2019 | 595 | 0.080 |
Why?
|
Burns | 1 | 2019 | 1815 | 0.080 |
Why?
|
Myocardial Infarction | 5 | 2020 | 11727 | 0.080 |
Why?
|
Prognosis | 13 | 2018 | 29063 | 0.080 |
Why?
|
Interdisciplinary Communication | 2 | 2011 | 950 | 0.080 |
Why?
|
Self Report | 3 | 2018 | 3558 | 0.080 |
Why?
|
Physical Fitness | 1 | 2012 | 733 | 0.080 |
Why?
|
Carcinoma | 2 | 2011 | 2375 | 0.080 |
Why?
|
Poverty | 4 | 2023 | 2660 | 0.080 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2007 | 2015 | 0.080 |
Why?
|
Cost-Benefit Analysis | 6 | 2023 | 5391 | 0.080 |
Why?
|
Faculty, Medical | 3 | 2011 | 1181 | 0.080 |
Why?
|
Opioid-Related Disorders | 2 | 2021 | 2065 | 0.080 |
Why?
|
Hodgkin Disease | 2 | 2007 | 1415 | 0.080 |
Why?
|
Pelvis | 3 | 2019 | 730 | 0.080 |
Why?
|
Device Approval | 1 | 2009 | 163 | 0.080 |
Why?
|
Asthma | 3 | 2004 | 6011 | 0.080 |
Why?
|
Receptor, Bradykinin B2 | 1 | 2007 | 24 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 5 | 2021 | 20129 | 0.080 |
Why?
|
Hernia, Ventral | 1 | 2010 | 176 | 0.080 |
Why?
|
Medical Informatics Applications | 1 | 2009 | 186 | 0.080 |
Why?
|
Costs and Cost Analysis | 4 | 2015 | 1681 | 0.080 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2009 | 264 | 0.080 |
Why?
|
Tobacco Smoke Pollution | 5 | 2006 | 816 | 0.080 |
Why?
|
Patient Admission | 2 | 2013 | 1380 | 0.080 |
Why?
|
Consumer Health Information | 1 | 2010 | 211 | 0.080 |
Why?
|
Models, Biological | 5 | 2010 | 9583 | 0.080 |
Why?
|
Morbidity | 5 | 2017 | 1769 | 0.080 |
Why?
|
Lymph Nodes | 3 | 2017 | 3474 | 0.080 |
Why?
|
Diagnosis | 1 | 2008 | 154 | 0.080 |
Why?
|
Face | 1 | 2013 | 994 | 0.070 |
Why?
|
Arthroplasty | 1 | 2010 | 305 | 0.070 |
Why?
|
Asia | 3 | 2015 | 610 | 0.070 |
Why?
|
Testosterone | 1 | 2018 | 2420 | 0.070 |
Why?
|
Nursing Staff, Hospital | 1 | 2010 | 346 | 0.070 |
Why?
|
Hip Fractures | 1 | 2015 | 955 | 0.070 |
Why?
|
Troponin I | 3 | 2008 | 619 | 0.070 |
Why?
|
Cross Infection | 3 | 2014 | 1416 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5221 | 0.070 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2011 | 365 | 0.070 |
Why?
|
Denmark | 3 | 2016 | 738 | 0.070 |
Why?
|
Paintings | 1 | 2008 | 101 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2012 | 1573 | 0.070 |
Why?
|
Interferon-alpha | 3 | 2002 | 895 | 0.070 |
Why?
|
Thoracic Surgical Procedures | 1 | 2011 | 342 | 0.070 |
Why?
|
Orthopedics | 1 | 2016 | 904 | 0.070 |
Why?
|
Troponin | 2 | 2003 | 524 | 0.070 |
Why?
|
Treatment Failure | 5 | 2015 | 2618 | 0.070 |
Why?
|
Diagnostic Imaging | 2 | 2011 | 3507 | 0.070 |
Why?
|
Multicenter Studies as Topic | 3 | 2021 | 1677 | 0.070 |
Why?
|
Israel | 3 | 2016 | 796 | 0.070 |
Why?
|
Emergency Medicine | 1 | 2016 | 1207 | 0.070 |
Why?
|
Prevalence | 7 | 2023 | 15226 | 0.070 |
Why?
|
Antimetabolites, Antineoplastic | 3 | 2002 | 640 | 0.070 |
Why?
|
Germany | 2 | 2018 | 862 | 0.070 |
Why?
|
Blood Loss, Surgical | 4 | 2012 | 662 | 0.070 |
Why?
|
Observation | 1 | 2008 | 312 | 0.070 |
Why?
|
Vitamin K | 1 | 2008 | 295 | 0.070 |
Why?
|
Head | 1 | 2012 | 880 | 0.070 |
Why?
|
Cryosurgery | 1 | 2011 | 453 | 0.070 |
Why?
|
Limb Salvage | 1 | 2008 | 433 | 0.070 |
Why?
|
Auranofin | 3 | 1999 | 15 | 0.070 |
Why?
|
Didanosine | 2 | 2010 | 153 | 0.070 |
Why?
|
Oxygen Consumption | 1 | 2012 | 1869 | 0.070 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 345 | 0.070 |
Why?
|
Tunica Media | 1 | 2006 | 113 | 0.070 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2010 | 2232 | 0.070 |
Why?
|
Back Pain | 1 | 2010 | 545 | 0.070 |
Why?
|
Diet | 4 | 2013 | 7939 | 0.070 |
Why?
|
Accidents, Traffic | 2 | 2021 | 819 | 0.070 |
Why?
|
Insurance Claim Review | 3 | 2019 | 720 | 0.070 |
Why?
|
Job Satisfaction | 1 | 2009 | 535 | 0.070 |
Why?
|
Bioprosthesis | 1 | 2010 | 596 | 0.070 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2010 | 496 | 0.070 |
Why?
|
New York | 6 | 2020 | 886 | 0.070 |
Why?
|
Intestinal Diseases | 1 | 2010 | 530 | 0.070 |
Why?
|
Emergency Medical Services | 3 | 2012 | 1917 | 0.060 |
Why?
|
Diagnosis-Related Groups | 2 | 2019 | 455 | 0.060 |
Why?
|
Severity of Illness Index | 6 | 2020 | 15540 | 0.060 |
Why?
|
Stents | 1 | 2017 | 3280 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 5 | 2022 | 35421 | 0.060 |
Why?
|
Arsenic | 2 | 1998 | 328 | 0.060 |
Why?
|
Comprehension | 1 | 2010 | 610 | 0.060 |
Why?
|
Teaching | 1 | 2013 | 1174 | 0.060 |
Why?
|
Arterial Occlusive Diseases | 1 | 2009 | 793 | 0.060 |
Why?
|
Cognition | 2 | 2023 | 6770 | 0.060 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2018 | 1813 | 0.060 |
Why?
|
Sensitivity and Specificity | 9 | 2015 | 14722 | 0.060 |
Why?
|
Workflow | 3 | 2016 | 847 | 0.060 |
Why?
|
Neurosurgical Procedures | 2 | 2020 | 2002 | 0.060 |
Why?
|
Energy Intake | 1 | 2013 | 2148 | 0.060 |
Why?
|
Rural Health Services | 2 | 2019 | 379 | 0.060 |
Why?
|
Melanoma | 2 | 2019 | 5510 | 0.060 |
Why?
|
Angioplasty | 1 | 2007 | 364 | 0.060 |
Why?
|
Disease | 1 | 2010 | 680 | 0.060 |
Why?
|
Workplace | 1 | 2011 | 836 | 0.060 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2008 | 506 | 0.060 |
Why?
|
Demography | 3 | 2018 | 1656 | 0.060 |
Why?
|
Enalapril | 2 | 2005 | 327 | 0.060 |
Why?
|
Heart Valve Diseases | 2 | 2010 | 1073 | 0.060 |
Why?
|
Water Pollutants, Chemical | 2 | 1998 | 311 | 0.060 |
Why?
|
Body Composition | 2 | 2013 | 2401 | 0.060 |
Why?
|
Graft Occlusion, Vascular | 1 | 2007 | 549 | 0.060 |
Why?
|
Streptozocin | 3 | 2007 | 196 | 0.060 |
Why?
|
Rural Health | 1 | 2006 | 305 | 0.060 |
Why?
|
Schizophrenia | 2 | 2011 | 6882 | 0.060 |
Why?
|
Caffeine | 1 | 2008 | 699 | 0.060 |
Why?
|
Zidovudine | 2 | 2010 | 620 | 0.060 |
Why?
|
Hospitals, University | 4 | 2009 | 571 | 0.060 |
Why?
|
Chronic Disease | 2 | 2017 | 9146 | 0.060 |
Why?
|
Chest Pain | 2 | 2021 | 1114 | 0.060 |
Why?
|
Hemoglobins | 3 | 2011 | 1534 | 0.060 |
Why?
|
Informed Consent | 1 | 2010 | 995 | 0.060 |
Why?
|
Evidence-Based Practice | 2 | 2020 | 500 | 0.060 |
Why?
|
Carcinoid Tumor | 1 | 2005 | 235 | 0.060 |
Why?
|
Ubiquinone | 1 | 2005 | 188 | 0.060 |
Why?
|
Tricuspid Valve | 1 | 2006 | 403 | 0.060 |
Why?
|
Medicare Part D | 1 | 2008 | 328 | 0.060 |
Why?
|
Tunica Intima | 1 | 2006 | 464 | 0.060 |
Why?
|
Documentation | 3 | 2022 | 871 | 0.060 |
Why?
|
Control Groups | 1 | 2023 | 105 | 0.060 |
Why?
|
Diabetic Foot | 1 | 2007 | 355 | 0.060 |
Why?
|
Thoracic Surgery | 1 | 2010 | 719 | 0.060 |
Why?
|
Mathematics | 2 | 1995 | 728 | 0.060 |
Why?
|
Carotid Artery, Internal | 1 | 2006 | 445 | 0.060 |
Why?
|
Physicians, Women | 1 | 2009 | 486 | 0.060 |
Why?
|
Risk Management | 1 | 2007 | 571 | 0.060 |
Why?
|
Cholesterol | 3 | 2012 | 2917 | 0.060 |
Why?
|
Liver Cirrhosis, Biliary | 2 | 2005 | 97 | 0.060 |
Why?
|
Clinical Laboratory Techniques | 1 | 2008 | 738 | 0.060 |
Why?
|
Hyperglycemia | 2 | 2010 | 1373 | 0.060 |
Why?
|
Learning | 1 | 2013 | 1713 | 0.060 |
Why?
|
Polymers | 1 | 2010 | 1621 | 0.060 |
Why?
|
Mediastinum | 1 | 2004 | 267 | 0.060 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2006 | 349 | 0.050 |
Why?
|
Clostridium Infections | 1 | 2009 | 548 | 0.050 |
Why?
|
Sleep Deprivation | 1 | 2009 | 832 | 0.050 |
Why?
|
Space Simulation | 1 | 2022 | 10 | 0.050 |
Why?
|
Educational Status | 4 | 2016 | 2540 | 0.050 |
Why?
|
Peptide Fragments | 2 | 2012 | 5097 | 0.050 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2022 | 165 | 0.050 |
Why?
|
Ambulatory Care Facilities | 2 | 2023 | 933 | 0.050 |
Why?
|
Vitamin A | 3 | 1996 | 615 | 0.050 |
Why?
|
Isoenzymes | 3 | 2003 | 1726 | 0.050 |
Why?
|
Reoperation | 5 | 2010 | 4201 | 0.050 |
Why?
|
Uncertainty | 1 | 2007 | 734 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2023 | 403 | 0.050 |
Why?
|
Myocytes, Cardiac | 2 | 2008 | 1637 | 0.050 |
Why?
|
Uremia | 1 | 2003 | 201 | 0.050 |
Why?
|
Parturition | 2 | 2018 | 441 | 0.050 |
Why?
|
Lung | 4 | 2024 | 9856 | 0.050 |
Why?
|
Africa | 2 | 2015 | 673 | 0.050 |
Why?
|
Infection Control | 1 | 2009 | 966 | 0.050 |
Why?
|
Physical Examination | 1 | 2008 | 1237 | 0.050 |
Why?
|
Anus Neoplasms | 2 | 1996 | 332 | 0.050 |
Why?
|
Colonoscopy | 2 | 2021 | 1367 | 0.050 |
Why?
|
User-Computer Interface | 2 | 2019 | 1431 | 0.050 |
Why?
|
Observer Variation | 2 | 2020 | 2593 | 0.050 |
Why?
|
Social Support | 1 | 2011 | 2118 | 0.050 |
Why?
|
Evaluation Studies as Topic | 3 | 2008 | 1681 | 0.050 |
Why?
|
Mothers | 4 | 2006 | 2165 | 0.050 |
Why?
|
Organizational Case Studies | 2 | 2014 | 299 | 0.050 |
Why?
|
Information Dissemination | 1 | 2010 | 1099 | 0.050 |
Why?
|
Geriatric Assessment | 2 | 2020 | 1372 | 0.050 |
Why?
|
Penile Erection | 2 | 2012 | 97 | 0.050 |
Why?
|
HIV Infections | 4 | 2015 | 16718 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7181 | 0.050 |
Why?
|
Tenascin | 1 | 2001 | 59 | 0.050 |
Why?
|
Creatine Kinase, MB Form | 3 | 2008 | 214 | 0.050 |
Why?
|
Stomach Diseases | 1 | 2002 | 134 | 0.050 |
Why?
|
Standard of Care | 2 | 2017 | 564 | 0.050 |
Why?
|
Biocompatible Materials | 1 | 2010 | 1736 | 0.050 |
Why?
|
Heart Valve Prosthesis | 1 | 2010 | 1488 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 204 | 0.050 |
Why?
|
Evidence-Based Nursing | 1 | 2020 | 16 | 0.050 |
Why?
|
Perineum | 2 | 2014 | 211 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4838 | 0.050 |
Why?
|
Drug Administration Schedule | 5 | 2012 | 4933 | 0.050 |
Why?
|
Lipoproteins | 1 | 2006 | 878 | 0.050 |
Why?
|
Safety | 3 | 2014 | 1186 | 0.050 |
Why?
|
Mortality | 3 | 2019 | 2864 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2007 | 1116 | 0.050 |
Why?
|
Adaptation, Psychological | 1 | 2011 | 2576 | 0.050 |
Why?
|
Cost of Illness | 2 | 2023 | 1859 | 0.050 |
Why?
|
Utah | 2 | 2016 | 126 | 0.050 |
Why?
|
Diabetic Angiopathies | 1 | 2006 | 818 | 0.050 |
Why?
|
North America | 2 | 2018 | 1249 | 0.050 |
Why?
|
Fatty Acids | 1 | 2008 | 1809 | 0.050 |
Why?
|
Ablation Techniques | 1 | 2023 | 249 | 0.050 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 546 | 0.050 |
Why?
|
Heart-Assist Devices | 1 | 2010 | 1194 | 0.050 |
Why?
|
Cholesterol, HDL | 2 | 2006 | 1814 | 0.050 |
Why?
|
Anti-HIV Agents | 2 | 2010 | 4256 | 0.050 |
Why?
|
Environment Design | 1 | 2022 | 178 | 0.050 |
Why?
|
American Cancer Society | 1 | 2019 | 61 | 0.050 |
Why?
|
Infant, Small for Gestational Age | 1 | 2023 | 440 | 0.050 |
Why?
|
Trimetrexate | 1 | 1999 | 15 | 0.050 |
Why?
|
Cholesterol, LDL | 3 | 2006 | 2356 | 0.050 |
Why?
|
Aortic Valve | 1 | 2010 | 1922 | 0.050 |
Why?
|
Diabetic Nephropathies | 1 | 2007 | 984 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4042 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1107 | 0.040 |
Why?
|
Human Growth Hormone | 1 | 2005 | 683 | 0.040 |
Why?
|
Disulfiram | 1 | 2020 | 57 | 0.040 |
Why?
|
Topotecan | 1 | 2000 | 137 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2023 | 591 | 0.040 |
Why?
|
Smoke Inhalation Injury | 1 | 2019 | 49 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2009 | 1863 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 631 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2005 | 1518 | 0.040 |
Why?
|
Stomach Neoplasms | 2 | 1999 | 1333 | 0.040 |
Why?
|
Urination Disorders | 2 | 2011 | 241 | 0.040 |
Why?
|
Harringtonines | 1 | 1999 | 8 | 0.040 |
Why?
|
Needs Assessment | 2 | 2018 | 1147 | 0.040 |
Why?
|
Serum Albumin | 2 | 2016 | 676 | 0.040 |
Why?
|
Birth Certificates | 1 | 2019 | 67 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 569 | 0.040 |
Why?
|
Single-Blind Method | 2 | 2014 | 1590 | 0.040 |
Why?
|
Neoplasms, Second Primary | 1 | 2007 | 1061 | 0.040 |
Why?
|
Gene Deletion | 1 | 2007 | 2751 | 0.040 |
Why?
|
Cholinergic Antagonists | 1 | 2020 | 165 | 0.040 |
Why?
|
Helicobacter pylori | 1 | 2002 | 382 | 0.040 |
Why?
|
Language | 2 | 2024 | 1471 | 0.040 |
Why?
|
Scotland | 1 | 2019 | 155 | 0.040 |
Why?
|
Helicobacter Infections | 1 | 2002 | 386 | 0.040 |
Why?
|
Technology | 1 | 2021 | 305 | 0.040 |
Why?
|
C-Reactive Protein | 4 | 2012 | 3778 | 0.040 |
Why?
|
Birth Weight | 2 | 2023 | 2069 | 0.040 |
Why?
|
Myocardial Contraction | 4 | 2010 | 1585 | 0.040 |
Why?
|
Gentamicins | 1 | 2019 | 255 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2023 | 643 | 0.040 |
Why?
|
Fresh Water | 1 | 1998 | 83 | 0.040 |
Why?
|
Acinetobacter baumannii | 1 | 2019 | 107 | 0.040 |
Why?
|
Clavicle | 1 | 2020 | 209 | 0.040 |
Why?
|
Histological Techniques | 1 | 2019 | 198 | 0.040 |
Why?
|
Advisory Committees | 1 | 2023 | 775 | 0.040 |
Why?
|
Minocycline | 1 | 2019 | 163 | 0.040 |
Why?
|
Iatrogenic Disease | 2 | 1992 | 547 | 0.040 |
Why?
|
Philosophy, Medical | 1 | 1998 | 79 | 0.040 |
Why?
|
Health Policy | 1 | 2011 | 2661 | 0.040 |
Why?
|
Obesity | 4 | 2022 | 12745 | 0.040 |
Why?
|
gamma-Globulins | 1 | 1998 | 124 | 0.040 |
Why?
|
Alginates | 1 | 2019 | 252 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 390 | 0.040 |
Why?
|
Interviews as Topic | 2 | 2017 | 2539 | 0.040 |
Why?
|
Rural Population | 4 | 2017 | 2210 | 0.040 |
Why?
|
Primary Nursing | 1 | 2017 | 11 | 0.040 |
Why?
|
Faculty | 1 | 2021 | 386 | 0.040 |
Why?
|
Eye Injuries, Penetrating | 1 | 2019 | 115 | 0.040 |
Why?
|
Mental Health Services | 2 | 2019 | 1643 | 0.040 |
Why?
|
Jaundice | 1 | 1998 | 89 | 0.040 |
Why?
|
Men's Health | 1 | 2018 | 73 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2011 | 2758 | 0.040 |
Why?
|
Motivation | 2 | 2022 | 1971 | 0.040 |
Why?
|
Hydroxyurea | 1 | 1999 | 290 | 0.040 |
Why?
|
Scleroderma, Systemic | 1 | 2001 | 323 | 0.040 |
Why?
|
Intestinal Neoplasms | 2 | 2010 | 319 | 0.040 |
Why?
|
Aging | 1 | 2016 | 8664 | 0.040 |
Why?
|
Poisons | 1 | 1997 | 34 | 0.040 |
Why?
|
Blood Urea Nitrogen | 2 | 2010 | 191 | 0.040 |
Why?
|
Subacute Care | 1 | 2019 | 168 | 0.040 |
Why?
|
Models, Economic | 2 | 2012 | 713 | 0.040 |
Why?
|
Creatine Kinase | 3 | 2006 | 694 | 0.040 |
Why?
|
Myoglobin | 2 | 2008 | 160 | 0.040 |
Why?
|
Organizational Innovation | 2 | 2011 | 559 | 0.040 |
Why?
|
Equipment Design | 2 | 2019 | 3582 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2019 | 977 | 0.040 |
Why?
|
Mexico | 1 | 2019 | 690 | 0.040 |
Why?
|
Blood Glucose | 2 | 2008 | 6256 | 0.040 |
Why?
|
Eye Color | 1 | 1996 | 36 | 0.040 |
Why?
|
Inappropriate Prescribing | 1 | 2019 | 202 | 0.040 |
Why?
|
Cardiovascular System | 1 | 2004 | 832 | 0.040 |
Why?
|
Postnatal Care | 1 | 2018 | 236 | 0.040 |
Why?
|
Calcinosis | 1 | 2005 | 1499 | 0.040 |
Why?
|
Shock, Hemorrhagic | 1 | 2018 | 220 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2002 | 1171 | 0.040 |
Why?
|
Government Agencies | 1 | 2017 | 156 | 0.040 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2006 | 1390 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2017 | 426 | 0.040 |
Why?
|
Antibodies, Bacterial | 1 | 2002 | 1470 | 0.040 |
Why?
|
Family Planning Services | 1 | 2019 | 263 | 0.040 |
Why?
|
Skin | 1 | 2010 | 4364 | 0.040 |
Why?
|
Vancomycin | 1 | 2019 | 501 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2011 | 4245 | 0.030 |
Why?
|
Protein Kinase C | 1 | 2001 | 1227 | 0.030 |
Why?
|
Drug Therapy | 1 | 1999 | 497 | 0.030 |
Why?
|
Surgical Wound Dehiscence | 1 | 2017 | 215 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6234 | 0.030 |
Why?
|
Acute Disease | 2 | 2020 | 7149 | 0.030 |
Why?
|
Vermont | 1 | 2016 | 85 | 0.030 |
Why?
|
Genes, ras | 1 | 1999 | 690 | 0.030 |
Why?
|
Menogaril | 1 | 1995 | 4 | 0.030 |
Why?
|
Oceania | 1 | 2015 | 17 | 0.030 |
Why?
|
Spouses | 1 | 2018 | 286 | 0.030 |
Why?
|
Neuroblastoma | 1 | 2004 | 1226 | 0.030 |
Why?
|
Cuba | 1 | 2015 | 47 | 0.030 |
Why?
|
Self-Assessment | 1 | 2018 | 390 | 0.030 |
Why?
|
Self Care | 1 | 2021 | 786 | 0.030 |
Why?
|
Americas | 1 | 2015 | 111 | 0.030 |
Why?
|
Moldova | 1 | 2015 | 15 | 0.030 |
Why?
|
Frail Elderly | 1 | 2020 | 693 | 0.030 |
Why?
|
Life Tables | 1 | 1996 | 370 | 0.030 |
Why?
|
Ethanol | 1 | 2022 | 1342 | 0.030 |
Why?
|
Ultrasonography | 5 | 2010 | 5985 | 0.030 |
Why?
|
Haiti | 1 | 2017 | 553 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2002 | 851 | 0.030 |
Why?
|
Costa Rica | 1 | 2015 | 177 | 0.030 |
Why?
|
Gastrostomy | 1 | 2018 | 309 | 0.030 |
Why?
|
Precancerous Conditions | 1 | 2002 | 975 | 0.030 |
Why?
|
Vascular Patency | 2 | 2008 | 886 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 2017 | 194 | 0.030 |
Why?
|
Hypercholesterolemia | 1 | 2002 | 1151 | 0.030 |
Why?
|
Respiratory Tract Diseases | 2 | 2002 | 722 | 0.030 |
Why?
|
Bleomycin | 1 | 1996 | 512 | 0.030 |
Why?
|
Health Care Rationing | 1 | 1998 | 437 | 0.030 |
Why?
|
Pain | 2 | 2023 | 4986 | 0.030 |
Why?
|
Death, Sudden, Cardiac | 2 | 2019 | 1541 | 0.030 |
Why?
|
Michigan | 1 | 2016 | 350 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2022 | 1257 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2017 | 275 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2016 | 2879 | 0.030 |
Why?
|
Oligonucleotides | 2 | 2008 | 572 | 0.030 |
Why?
|
Death | 1 | 2020 | 678 | 0.030 |
Why?
|
Chile | 1 | 2015 | 237 | 0.030 |
Why?
|
Women's Health | 3 | 2009 | 2034 | 0.030 |
Why?
|
Community Health Services | 1 | 2000 | 650 | 0.030 |
Why?
|
Fetal Death | 1 | 2016 | 448 | 0.030 |
Why?
|
Tissue Adhesions | 1 | 2016 | 235 | 0.030 |
Why?
|
Health Personnel | 2 | 2023 | 3218 | 0.030 |
Why?
|
Wound Healing | 2 | 2019 | 2785 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2015 | 520 | 0.030 |
Why?
|
China | 2 | 2015 | 2248 | 0.030 |
Why?
|
Systems Integration | 1 | 2016 | 440 | 0.030 |
Why?
|
Time | 1 | 2016 | 542 | 0.030 |
Why?
|
Obstetrics | 2 | 2013 | 658 | 0.030 |
Why?
|
Hydrogels | 1 | 2019 | 724 | 0.030 |
Why?
|
Cocaine | 1 | 2020 | 1007 | 0.030 |
Why?
|
Direct Service Costs | 1 | 2014 | 62 | 0.030 |
Why?
|
Critical Pathways | 1 | 2018 | 476 | 0.030 |
Why?
|
Nursing Records | 1 | 2013 | 28 | 0.030 |
Why?
|
Ribavirin | 1 | 1996 | 395 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2029 | 0.030 |
Why?
|
Xerophthalmia | 1 | 1993 | 18 | 0.030 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2014 | 57 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2019 | 1877 | 0.030 |
Why?
|
Exercise | 2 | 2020 | 5615 | 0.030 |
Why?
|
Independent Living | 1 | 2018 | 568 | 0.030 |
Why?
|
El Salvador | 1 | 2013 | 39 | 0.030 |
Why?
|
Osteosarcoma | 2 | 1996 | 881 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 868 | 0.030 |
Why?
|
Nursing Informatics | 1 | 2013 | 42 | 0.030 |
Why?
|
Interferon-beta | 1 | 1995 | 323 | 0.030 |
Why?
|
Vital Statistics | 1 | 2013 | 34 | 0.030 |
Why?
|
Vitamin A Deficiency | 1 | 1994 | 101 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2044 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6756 | 0.030 |
Why?
|
Patient Preference | 1 | 2020 | 890 | 0.030 |
Why?
|
Graft Rejection | 2 | 2010 | 4397 | 0.030 |
Why?
|
Colon | 1 | 2021 | 1772 | 0.030 |
Why?
|
Disease Progression | 4 | 2006 | 13284 | 0.030 |
Why?
|
Preoperative Period | 1 | 2015 | 549 | 0.030 |
Why?
|
Feedback, Psychological | 1 | 2012 | 97 | 0.030 |
Why?
|
France | 1 | 2013 | 517 | 0.030 |
Why?
|
Adenoma, Islet Cell | 1 | 1992 | 82 | 0.030 |
Why?
|
Curriculum | 2 | 2017 | 3605 | 0.030 |
Why?
|
Information Systems | 1 | 2014 | 410 | 0.030 |
Why?
|
Myocardium | 2 | 2012 | 4776 | 0.030 |
Why?
|
Pseudomonas aeruginosa | 1 | 2019 | 1219 | 0.030 |
Why?
|
Constriction | 1 | 2012 | 181 | 0.030 |
Why?
|
Acetazolamide | 1 | 1992 | 100 | 0.030 |
Why?
|
Reimbursement, Incentive | 1 | 2017 | 540 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2023 | 2690 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2017 | 921 | 0.030 |
Why?
|
Live Birth | 1 | 2015 | 512 | 0.030 |
Why?
|
Perphenazine | 1 | 2011 | 34 | 0.030 |
Why?
|
Societies, Medical | 2 | 2016 | 3743 | 0.020 |
Why?
|
Exercise Test | 2 | 2012 | 2074 | 0.020 |
Why?
|
Decision Making | 2 | 2016 | 3887 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2019 | 1451 | 0.020 |
Why?
|
Perioperative Care | 1 | 2019 | 1002 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10638 | 0.020 |
Why?
|
Communication Barriers | 1 | 2014 | 398 | 0.020 |
Why?
|
Hospital Departments | 1 | 2011 | 137 | 0.020 |
Why?
|
Anesthesia Department, Hospital | 1 | 2011 | 68 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2006 | 3336 | 0.020 |
Why?
|
Malignant Hyperthermia | 1 | 2011 | 73 | 0.020 |
Why?
|
Hysterectomy | 1 | 2017 | 927 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3305 | 0.020 |
Why?
|
Economics, Hospital | 1 | 1993 | 213 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10943 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2005 | 2775 | 0.020 |
Why?
|
Ownership | 1 | 2013 | 332 | 0.020 |
Why?
|
Nursing Methodology Research | 1 | 2010 | 67 | 0.020 |
Why?
|
Affect | 1 | 1999 | 1476 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2012 | 288 | 0.020 |
Why?
|
Dibenzothiazepines | 1 | 2011 | 103 | 0.020 |
Why?
|
Embolism, Air | 1 | 2011 | 111 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1995 | 624 | 0.020 |
Why?
|
Organizational Culture | 1 | 2014 | 510 | 0.020 |
Why?
|
Personality | 1 | 2014 | 552 | 0.020 |
Why?
|
Animals | 7 | 2023 | 168757 | 0.020 |
Why?
|
Fat Necrosis | 1 | 2010 | 58 | 0.020 |
Why?
|
Heart Transplantation | 2 | 2002 | 3110 | 0.020 |
Why?
|
Awareness | 1 | 2015 | 640 | 0.020 |
Why?
|
Mitomycin | 2 | 2005 | 259 | 0.020 |
Why?
|
Role Playing | 1 | 2010 | 24 | 0.020 |
Why?
|
Reference Values | 2 | 2009 | 4982 | 0.020 |
Why?
|
Africa, Northern | 1 | 2010 | 82 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 1996 | 2242 | 0.020 |
Why?
|
Coronary Artery Disease | 2 | 2012 | 6487 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2959 | 0.020 |
Why?
|
Photography | 1 | 2013 | 520 | 0.020 |
Why?
|
Liability, Legal | 1 | 1992 | 213 | 0.020 |
Why?
|
Epigastric Arteries | 1 | 2010 | 96 | 0.020 |
Why?
|
Urban Population | 2 | 2009 | 2021 | 0.020 |
Why?
|
Transferrin | 1 | 2011 | 295 | 0.020 |
Why?
|
Endoscopy | 1 | 2020 | 1785 | 0.020 |
Why?
|
Double-Blind Method | 3 | 2010 | 12026 | 0.020 |
Why?
|
Housekeeping, Hospital | 1 | 2009 | 17 | 0.020 |
Why?
|
Social Class | 2 | 2016 | 1999 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 3 | 1999 | 3712 | 0.020 |
Why?
|
Software Design | 1 | 1990 | 176 | 0.020 |
Why?
|
Middle East | 1 | 2010 | 219 | 0.020 |
Why?
|
Utilization Review | 1 | 2011 | 392 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2016 | 788 | 0.020 |
Why?
|
New Zealand | 1 | 2010 | 355 | 0.020 |
Why?
|
Ligation | 1 | 2010 | 453 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2017 | 1584 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2012 | 684 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 2016 | 931 | 0.020 |
Why?
|
Hernia, Abdominal | 1 | 2010 | 53 | 0.020 |
Why?
|
Swine | 1 | 2019 | 5917 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2013 | 600 | 0.020 |
Why?
|
Switzerland | 1 | 2009 | 255 | 0.020 |
Why?
|
Mental Disorders | 2 | 1999 | 6600 | 0.020 |
Why?
|
Puerto Rico | 1 | 2010 | 356 | 0.020 |
Why?
|
Specialty Boards | 1 | 2011 | 227 | 0.020 |
Why?
|
Urinary Catheterization | 1 | 2010 | 202 | 0.020 |
Why?
|
Traction | 1 | 2009 | 106 | 0.020 |
Why?
|
Students, Medical | 2 | 2014 | 1862 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2011 | 392 | 0.020 |
Why?
|
Radiography | 2 | 2011 | 7023 | 0.020 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1992 | 317 | 0.020 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 94 | 0.020 |
Why?
|
Latin America | 1 | 2010 | 381 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2002 | 3870 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1170 | 0.020 |
Why?
|
Diastole | 2 | 2002 | 791 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2010 | 1162 | 0.020 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2010 | 101 | 0.020 |
Why?
|
Tissue Expansion Devices | 1 | 2010 | 156 | 0.020 |
Why?
|
ROC Curve | 2 | 2011 | 3527 | 0.020 |
Why?
|
Vocal Cord Paralysis | 1 | 2012 | 267 | 0.020 |
Why?
|
Group Processes | 1 | 2010 | 225 | 0.020 |
Why?
|
Organizational Policy | 1 | 2011 | 429 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2005 | 859 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3339 | 0.020 |
Why?
|
Poverty Areas | 1 | 2010 | 275 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4297 | 0.020 |
Why?
|
Age of Onset | 2 | 2011 | 3271 | 0.020 |
Why?
|
Breast | 1 | 2017 | 1969 | 0.020 |
Why?
|
Apgar Score | 1 | 2008 | 123 | 0.020 |
Why?
|
Self Disclosure | 1 | 2009 | 251 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1240 | 0.020 |
Why?
|
Medically Underserved Area | 1 | 2010 | 253 | 0.020 |
Why?
|
Program Development | 1 | 2014 | 1316 | 0.020 |
Why?
|
Licensure, Medical | 1 | 2008 | 62 | 0.020 |
Why?
|
Disclosure | 1 | 2014 | 736 | 0.020 |
Why?
|
Marriage | 1 | 2009 | 339 | 0.020 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2015 | 1320 | 0.020 |
Why?
|
Dissection | 1 | 2009 | 295 | 0.020 |
Why?
|
Exercise Therapy | 1 | 2014 | 906 | 0.020 |
Why?
|
Health Plan Implementation | 1 | 2011 | 352 | 0.020 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2007 | 67 | 0.020 |
Why?
|
Spinal Cord Injuries | 1 | 2015 | 931 | 0.020 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2011 | 360 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2010 | 724 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 2012 | 650 | 0.020 |
Why?
|
Developed Countries | 1 | 2010 | 437 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2014 | 1504 | 0.020 |
Why?
|
Paclitaxel | 1 | 1995 | 1708 | 0.020 |
Why?
|
Lung Diseases | 1 | 2017 | 1886 | 0.020 |
Why?
|
Connective Tissue Growth Factor | 1 | 2007 | 96 | 0.020 |
Why?
|
Home Care Services | 1 | 2013 | 606 | 0.020 |
Why?
|
Mass Media | 1 | 2010 | 305 | 0.020 |
Why?
|
Negotiating | 1 | 2008 | 133 | 0.020 |
Why?
|
Diet, Sodium-Restricted | 1 | 2009 | 287 | 0.020 |
Why?
|
Policy Making | 1 | 2011 | 554 | 0.020 |
Why?
|
Gestational Age | 1 | 2015 | 3493 | 0.020 |
Why?
|
Australia | 1 | 2010 | 1170 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2014 | 1125 | 0.020 |
Why?
|
Seizures | 1 | 2019 | 2859 | 0.020 |
Why?
|
Hormones | 1 | 2011 | 889 | 0.020 |
Why?
|
Taiwan | 2 | 1998 | 496 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2010 | 987 | 0.020 |
Why?
|
Scientific Misconduct | 1 | 2007 | 71 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2007 | 205 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2012 | 879 | 0.020 |
Why?
|
Recurrence | 2 | 2010 | 8340 | 0.020 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1995 | 990 | 0.020 |
Why?
|
Wisconsin | 1 | 2006 | 124 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1725 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2459 | 0.020 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2008 | 194 | 0.020 |
Why?
|
Physician Assistants | 1 | 2009 | 193 | 0.020 |
Why?
|
Hemodynamics | 2 | 2008 | 4199 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2013 | 1547 | 0.020 |
Why?
|
Breast Implants | 1 | 2010 | 387 | 0.020 |
Why?
|
Electric Impedance | 1 | 2010 | 729 | 0.020 |
Why?
|
Hospitals, Private | 1 | 2006 | 63 | 0.020 |
Why?
|
Focus Groups | 1 | 2010 | 1321 | 0.020 |
Why?
|
Counseling | 1 | 2014 | 1523 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2010 | 705 | 0.020 |
Why?
|
Necrosis | 1 | 2010 | 1643 | 0.020 |
Why?
|
Nurse Practitioners | 1 | 2009 | 270 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
Models, Educational | 1 | 2008 | 377 | 0.020 |
Why?
|
Urologic Surgical Procedures | 1 | 2008 | 302 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2010 | 599 | 0.020 |
Why?
|
Pericardium | 1 | 2010 | 667 | 0.020 |
Why?
|
Accreditation | 1 | 2008 | 450 | 0.020 |
Why?
|
Specimen Handling | 1 | 2010 | 694 | 0.020 |
Why?
|
Heart Rate | 2 | 2008 | 4091 | 0.020 |
Why?
|
Penicillamine | 1 | 2005 | 59 | 0.020 |
Why?
|
Body Temperature | 1 | 2008 | 777 | 0.020 |
Why?
|
Social Environment | 1 | 2010 | 1023 | 0.020 |
Why?
|
Memory | 1 | 2014 | 2174 | 0.020 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 514 | 0.020 |
Why?
|
Anesthesia | 1 | 2016 | 1561 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2010 | 1206 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 2007 | 453 | 0.020 |
Why?
|
Cervix Uteri | 1 | 2008 | 590 | 0.020 |
Why?
|
Device Removal | 1 | 2009 | 656 | 0.020 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2004 | 60 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 2006 | 517 | 0.010 |
Why?
|
Health Literacy | 1 | 2009 | 414 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2000 | 4034 | 0.010 |
Why?
|
Environmental Exposure | 1 | 1998 | 4234 | 0.010 |
Why?
|
Sudan | 2 | 1994 | 83 | 0.010 |
Why?
|
Anaphylaxis | 1 | 2011 | 746 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 1996 | 2529 | 0.010 |
Why?
|
Catheterization | 1 | 2009 | 1470 | 0.010 |
Why?
|
Mice | 4 | 2009 | 81183 | 0.010 |
Why?
|
Tissue Scaffolds | 1 | 2010 | 956 | 0.010 |
Why?
|
Gynecology | 1 | 2009 | 513 | 0.010 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2007 | 469 | 0.010 |
Why?
|
Geography | 1 | 2006 | 669 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2010 | 2110 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2015 | 2026 | 0.010 |
Why?
|
Hypopituitarism | 1 | 2005 | 254 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1995 | 2214 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2005 | 1420 | 0.010 |
Why?
|
Chelating Agents | 1 | 2004 | 380 | 0.010 |
Why?
|
Japan | 1 | 2007 | 1360 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 2006 | 640 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2006 | 1799 | 0.010 |
Why?
|
Heart Block | 1 | 2004 | 410 | 0.010 |
Why?
|
Renin-Angiotensin System | 1 | 2007 | 759 | 0.010 |
Why?
|
Mental Recall | 1 | 2009 | 1205 | 0.010 |
Why?
|
Floxuridine | 1 | 2002 | 49 | 0.010 |
Why?
|
Peritoneal Dialysis | 1 | 2003 | 146 | 0.010 |
Why?
|
Hospital Records | 2 | 1993 | 95 | 0.010 |
Why?
|
Colorado | 1 | 2002 | 163 | 0.010 |
Why?
|
Fatigue | 1 | 2009 | 1531 | 0.010 |
Why?
|
Hypotension | 1 | 2008 | 884 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2007 | 1641 | 0.010 |
Why?
|
Medicine | 1 | 2010 | 946 | 0.010 |
Why?
|
International Classification of Diseases | 1 | 2007 | 867 | 0.010 |
Why?
|
Tachycardia | 1 | 2004 | 619 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 2002 | 234 | 0.010 |
Why?
|
Low Back Pain | 1 | 2010 | 956 | 0.010 |
Why?
|
Fetal Blood | 1 | 2008 | 1318 | 0.010 |
Why?
|
Protein Kinase C-epsilon | 1 | 2001 | 43 | 0.010 |
Why?
|
Biomedical Research | 1 | 2017 | 3309 | 0.010 |
Why?
|
Hyperparathyroidism | 1 | 2003 | 339 | 0.010 |
Why?
|
Thorax | 1 | 2004 | 547 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2007 | 1530 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1999 | 5181 | 0.010 |
Why?
|
Hepatic Artery | 1 | 2002 | 245 | 0.010 |
Why?
|
Tissue Donors | 1 | 2010 | 2240 | 0.010 |
Why?
|
Anthropometry | 1 | 2005 | 1350 | 0.010 |
Why?
|
Anemia | 1 | 2010 | 1506 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2006 | 1133 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2012 | 2541 | 0.010 |
Why?
|
Cisplatin | 2 | 1996 | 1662 | 0.010 |
Why?
|
Pain Measurement | 1 | 2010 | 3420 | 0.010 |
Why?
|
Graft Survival | 1 | 2010 | 3737 | 0.010 |
Why?
|
Patient Transfer | 1 | 2007 | 761 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1676 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1144 | 0.010 |
Why?
|
Pediatrics | 1 | 2014 | 3475 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2001 | 1581 | 0.010 |
Why?
|
Education, Medical, Undergraduate | 1 | 2008 | 1008 | 0.010 |
Why?
|
Agranulocytosis | 1 | 1999 | 101 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1998 | 5686 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2001 | 768 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 2001 | 433 | 0.010 |
Why?
|
Placebos | 1 | 2003 | 1676 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12951 | 0.010 |
Why?
|
Heart Conduction System | 1 | 2004 | 1047 | 0.010 |
Why?
|
Body Height | 1 | 2005 | 1577 | 0.010 |
Why?
|
Thrombin | 1 | 2001 | 598 | 0.010 |
Why?
|
Epidemiologic Research Design | 1 | 2002 | 367 | 0.010 |
Why?
|
Connecticut | 1 | 1999 | 366 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2003 | 1730 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2010 | 3279 | 0.010 |
Why?
|
Triglycerides | 1 | 2006 | 2454 | 0.010 |
Why?
|
Electrocardiography | 2 | 2004 | 6442 | 0.010 |
Why?
|
Life Style | 1 | 2009 | 3835 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 2 | 2006 | 3537 | 0.010 |
Why?
|
Antibodies | 1 | 2006 | 2460 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2011 | 3057 | 0.010 |
Why?
|
Weight Loss | 1 | 2009 | 2622 | 0.010 |
Why?
|
Myelodysplastic Syndromes | 1 | 2007 | 1352 | 0.010 |
Why?
|
Respiratory Tract Infections | 1 | 2004 | 961 | 0.010 |
Why?
|
Codon | 1 | 1999 | 611 | 0.010 |
Why?
|
Leucovorin | 1 | 1999 | 628 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 11725 | 0.010 |
Why?
|
Patient Dropouts | 1 | 1999 | 421 | 0.010 |
Why?
|
Urbanization | 1 | 1997 | 104 | 0.010 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 1996 | 88 | 0.010 |
Why?
|
Total Lung Capacity | 1 | 1996 | 143 | 0.010 |
Why?
|
Dactinomycin | 1 | 1996 | 318 | 0.010 |
Why?
|
Stomatitis | 1 | 1999 | 269 | 0.010 |
Why?
|
Overweight | 1 | 2007 | 2371 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1996 | 424 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 1996 | 418 | 0.010 |
Why?
|
Nutritional Status | 2 | 1994 | 1609 | 0.010 |
Why?
|
Fever | 1 | 2002 | 1616 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11366 | 0.010 |
Why?
|
Mutation | 1 | 1999 | 29786 | 0.010 |
Why?
|
Rats | 1 | 2010 | 24260 | 0.010 |
Why?
|
Medical Indigency | 1 | 1993 | 64 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2003 | 1786 | 0.010 |
Why?
|
Sleep | 1 | 2009 | 4623 | 0.010 |
Why?
|
Financial Management, Hospital | 1 | 1993 | 74 | 0.010 |
Why?
|
Air Pollutants | 1 | 2006 | 2817 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2007 | 14557 | 0.010 |
Why?
|
Kidney | 1 | 2007 | 7186 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2007 | 3523 | 0.010 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 1993 | 303 | 0.010 |
Why?
|
Forced Expiratory Volume | 1 | 1996 | 1743 | 0.010 |
Why?
|
Remission Induction | 1 | 1996 | 2386 | 0.010 |
Why?
|
Fibroblasts | 1 | 2001 | 4161 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2002 | 4560 | 0.010 |
Why?
|
Cough | 1 | 1994 | 555 | 0.010 |
Why?
|
Methotrexate | 1 | 1996 | 1727 | 0.010 |
Why?
|
Hospitals, Rural | 1 | 1991 | 172 | 0.010 |
Why?
|
Neutropenia | 1 | 1995 | 895 | 0.010 |
Why?
|
Radiotherapy | 1 | 1996 | 1533 | 0.010 |
Why?
|
Antirheumatic Agents | 1 | 1999 | 1339 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2002 | 3848 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1996 | 6314 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18029 | 0.000 |
Why?
|
Diarrhea | 1 | 1994 | 1348 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2001 | 13033 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2001 | 19229 | 0.000 |
Why?
|
Signal Transduction | 1 | 2001 | 23403 | 0.000 |
Why?
|